← FDA Drug Approvals (Drugs@FDA)

OMEPRAZOLE AND SODIUM BICARBONATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROLIFE PHARMA LLC · Approved 2016-08-19

Drug application

FDA Application #

ANDA204922

Application type

Abbreviated New Drug Application (Generic)

Brand name

OMEPRAZOLE AND SODIUM BICARBONATE

Generic name

Omeprazole

Active ingredients

OMEPRAZOLE; SODIUM BICARBONATE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

AUROLIFE PHARMA LLC

First approval

2016-08-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown